We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KBR:NYSEKBR, Inc. Analysis

Data as of 2026-05-21 - not real-time

$31.59

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

KBR trades at $31.59, sitting below its 20‑day SMA of $33.88 and 50‑day SMA of $35.73, with the 200‑day SMA still at $42.23, signaling a clear bearish price trend. The RSI of 38 and a bearish MACD histogram reinforce the downside momentum, while the stock hovers just above the identified support level of $29.94 and faces resistance near $39.07. Volatility is elevated at over 43% (30‑day) and a beta of 0.77 points to heightened sensitivity to market swings.
Fundamentally, KBR appears cheap relative to peers – its trailing PE of 9.3 is far below the industry average of 29.3 and its price‑to‑sales ratio is only 0.52. The company yields 2.04% dividend with a modest 19% payout, supported by solid ROE of 29% and free cash flow of $250 M. However, revenue contracted 5% YoY, gross margins sit at just 14.5%, and a debt‑to‑equity ratio of 177% reflects a heavy leverage burden, with net debt far exceeding cash on hand. A discounted cash‑flow model places fair value near $6.26, implying substantial downside from current pricing, though a recent $449 M Army contract award and a newly declared quarterly dividend provide short‑term upside catalysts.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below key moving averages and bearish MACD
  • High short‑term volatility and proximity to support
  • Dividend yield provides limited cushion

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Attractive valuation multiples versus industry peers
  • Stable dividend and solid ROE
  • Potential upside from government contract pipeline

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount (PE, price‑to‑sales)
  • Consistent dividend and strong cash generation
  • Long‑run secular demand for engineering and decarbonization services

Key Metrics & Analysis

Financial Health

Revenue Growth-4.70%
Profit Margin5.21%
P/E Ratio9.3
ROE29.15%
ROA4.98%
Debt/Equity176.90
P/B Ratio2.7
Op. Cash Flow$534.0M
Free Cash Flow$250.4M
Industry P/E29.3

Technical Analysis

TrendBearish
RSI38.1
Support$29.94
Resistance$39.07
MA 20$33.88
MA 50$35.73
MA 200$42.23
MACDBearish
VolumeStable
Fear & Greed Index89.68

Valuation

Fair Value$6.26
Target Price$48.63
Upside/Downside53.93%
GradeUndervalued
TypeValue
Dividend Yield2.04%

Risk Assessment

Beta0.77
Volatility43.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.